Comprehensive Peptide Synthesis Report: Insights into
Therapeutics and Nutraceuticals Usage for Disease
Management
BOSTON, May 2, 2024
/PRNewswire/ -- According to the latest BCC Research study, the
demand for Peptide Synthesis: Global Markets is growing from
$90.1 billion in 2023 to $157.5 billion by the end of 2028, at a compound
annual growth rate (CAGR) of 11.8% from 2023 through 2028.
The report on peptide synthesis covers everything from the types
of peptides to their applications and how they're made. It's like a
big picture of the market, including who's doing what, what's
selling where, and what's coming up next. It's handy for businesses
deciding what to make or invest in and for anyone interested in
market trends. The report looks at the market from all angles -
from cancer treatments to cosmetics - and breaks it down by
regions, like North America and
Asia-Pacific. It uses data from
2022 as a starting point and predicts where things are headed by
2028.
Meanwhile, the best-selling drug, Ozempic, will not be available
until December 2024 due to high
demand and limited production. At the same time, obesity is a
silent killer that is increasingly affecting young people, leading
to earlier onset of heart disease, and underscoring the urgent need
for preventive measures.
To know more about Peptide Synthesis: Global Market Report,
click here for details.
Key Drivers of Peptide Synthesis: Global Markets
Developments in Peptide Drug Delivery: Recent advances in
drug delivery, such as sustained-release formulations and targeted
systems, have improved the efficacy and patient compliance of
peptide therapy. New techniques such as nanoparticles and
microneedles promise further optimization.
Rising Prevalence of Chronic Diseases: The increase in
the number of chronic diseases in the world creates the need for
effective treatment. The peptide's specificity, minimal side
effects, and pathway-modulating effects make it a promising
candidate for the treatment of these diseases, especially as the
population ages.
Increase in Biotech Spending: The biotech industry is
investing heavily in peptide research and development to drive
innovation and market growth. Companies, institutions, and
pharmaceutical giants are allocating resources to peptide
discovery, synthesis, and clinical trials, accelerating the
development of peptide therapies.
Increase in Infectious and Chronic Diseases: Despite
advances in treatment, infectious diseases persist, forcing the
search for new treatments. Peptides provide a solution with their
antimicrobial properties. In addition, peptides play an important
role in the treatment of chronic diseases such as cancer and
neurodegenerative diseases, demonstrating their versatility in
addressing a variety of health problems.
Request a Sample Copy of the Peptide
Synthesis: Global Markets Report.
Report Synopsis
Report
Metrics
|
Details
|
Base year
considered
|
2022
|
Forecast Period
considered
|
2023-2028
|
Base year market
size
|
$83.7
billion
|
Market Size
Forecast
|
$157.5
billion
|
Growth Rate
|
CAGR of 11.8% for the
forecast period of 2023-2028
|
Segment
Covered
|
Type, Synthesis Type,
Application, and Region
|
Regions
covered
|
North America, Europe,
Asia-Pacific, and Rest of the World
|
Countries
covered
|
U.S., Mexico, Canada,
Germany, France, U.K., Spain, Italy, China, Japan, India,
Australia, and New Zealand, GCC countries, Brazil
|
Key Market
Drivers
|
- Developments in
peptide drug delivery.
- Rising prevalence
of chronic diseases.
- Increase in biotech
spending.
- Increase in
infectious and chronic diseases
|
Segmentation Analysis:
Synthesis Types: Solid-phase synthesis can efficiently
construct peptides on solid supports. Solution-phase synthesis
offers flexibility but is less efficient for longer peptides.
Mixed-phase synthesis combines both approaches to increase
efficiency and flexibility.
Applications: In cosmetics, peptides can improve collagen
and improve skin. Nutritional formulations use bioactive peptides
to promote health. Peptides are also applicable in agriculture,
food, and materials science.
Peptide Therapeutics: In cancer, peptides target specific
pathways. In diabetes, they regulate insulin. In neurology,
peptides can treat neurodegenerative diseases. They also show
promise in cardiology and rare diseases.
Peptide Types: Synthetic peptides are specially designed.
Antimicrobial peptides fight infections. Hormonal peptides regulate
hormones. Bioactive peptides affect biology. Collagen peptides
support skin and joints. Other professional categories serve
specific purposes.Top of Form
This report on Peptide Synthesis: Global Market provides a
comprehensive insight and analysis that addresses the following key
questions:
Some of the Key Market Players Are:
- ABBOTT
- ABBVIE INC.
- AMGEN INC.
- ASTRAZENECA
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- BRISTOL MYERS SQUIBB CO.
- B. BRAUN SE
- LILLY
- MERCK & CO. INC.
- MODERNA INC.
- NOVARTIS AG
- NOVO NORDISK A/S
- SANOFI
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
Browse More Related Reports:
Biologic Therapeutic Drugs: Technologies and Global
Markets: This report on the biologics market provides a
comprehensive analysis of its current state and prospects. The
report covers aspects such as competitive dynamics, regulatory
environment, and market trends, providing an in-depth understanding
of key players and market shares in various product categories such
as therapeutic proteins, cell and gene therapies, and vaccines. It
also examines market segmentation by application and source, along
with a detailed regional analysis. The report uses 2022 as a base
year and extends projections to 2028, all in constant dollars.
Global Market for Anti-obesity Drugs: The
Anti-Obesity Drugs report provides an overview of the global
market, analyzes trends, and forecasts CAGR from 2022 to 2028.
Covers pharmaceutical types, distribution channels, and product
lines of major companies. Market segmentation includes prescription
and over-the-counter drugs distributed through hospitals, retail
pharmacies, and online. The regions analyzed include North America, Europe, Asia
Pacific, and the rest of the world.
Directly Purchase a copy of the
report with BCC Research.
For further information or to make a purchase, please get in
touch with info@bccresearch.com.
About BCC Research
BCC Research provides objective, unbiased measurement and
assessment of market opportunities with detailed market research
reports. Our experienced industry analysts' goal is to help you
make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St. Ste 16,
Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit
our media page for access to our market research library.
Data and analysis extracted from this press release must be
accompanied by a statement identifying BCC Research LLC as the
source and publisher.
Logo:
https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/peptide-synthesis-global-markets-projected-to-reach-157-5-billion-by-2028--according-to-bcc-research-analysis-302134249.html
SOURCE BCC Research LLC